Ryman Healthcare Limited logo

Ryman Healthcare debt facilities update

Debt Issuance9 September 2024RYMHealthcare

NZX RELEASE

10 September 2024



Debt facilities update


Ryman Healthcare (Ryman) has agreed amendments to its debt covenants and extended one

of its banking facilities.


Ryman’s interest coverage ratio (ICR) covenant levels, which apply to both bank facilities

and its institutional term loan (ITL), have been amended for testing periods through to

March 2026 (see table below). The ICR covenant level remains at 2.25x for testing periods

beyond this. There has been no change to the ICR covenant calculation (being adjusted

EBITDA to gross interest expense

1

), Ryman’s other financial covenants or Ryman’s loan

margins.


Chief Financial Officer Rob Woodgate said, “As signaled in our Business Improvement

Performance Update on 2 September 2024, given the continued uncertainty around

residential property market conditions in the near term, we believe a prudent step is to

attain additional covenant headroom for upcoming testing periods. Discussions with our

lenders have been positive and they remain very supportive of Ryman.”


In addition, a $115 million bank facility, previously maturing on 30 September 2024,

has been extended to 1 April 2026.


Ryman’s debt facilities total NZ$3, 018 million which comprises syndicated bank facilities of

NZ$2,598 million

2

, a retail bond of NZ$150 million and an ITL of A$250 million. The

average term to maturity across all facilities is 2. 8 years at 10 September 2024.


Covenant testing period Previous ICR Amended ICR

12 months to 30 September 2024 1.75x 1.50x

12 months to 31 March 2025 1.75x 1.50x

12 months to 30 September 2025 2.00x 1.75x

12 months to 31 March 2026 2.25x 2.00x




ENDS





About Ryman:

Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49

retirement villages in New Zealand and Australia. Ryman villages are home to 14,600

residents, and the company employs 7,700 staff.


Contacts:

For investor relations information contact Hayden Strickett, Head of Investor Relations, on

027 303 1132 (+64 27 303 1132) or email hayden.strickett@rymanhealthcare.com


For media information or images contact Camille Middleditch on 028 422 3472 or

camille.middleditch@rymanexternal.com


1: See Appendix 11 in Ryman Healthcare’s 2024 result presentation for further detail (link).

2: Includes Australian dollar and multi-currency facilities, both presented in New Zealand

dollars.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.